Physician profile
William Russell
NPI 1689674954
$3,149.07
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $574 · 2021: $1,247 · 2022: $113 · 2023: $16.17 · 2024: $24.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $579.53 | 2019-2021 | |
| Janssen Biotech, INC. | $530.92 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $314.70 | 2019-2021 | |
| Pfizer INC. | $244.62 | 2019-2021 | |
| 180 Medical, INC. | $214.01 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $158.07 | 2019-2021 | |
| Blue Earth Diagnostics | $122.64 | 2019-2022 | |
| Amgen INC. | $98.14 | 2019-2021 | |
| Coloplast Corp | $93.76 | 2021-2023 | Speedicath |
| Myovant Sciences INC. | $91.06 | 2021 | |
| Boston Scientific Corporation | $82.43 | 2019-2021 | |
| Acerus Pharmaceuticals Corporation | $69.63 | 2020-2021 | |
| Allergan, INC. | $66.12 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $49.56 | 2020-2021 | |
| Hollister Incorporated | $46.46 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $44.56 | 2019-2024 | |
| Palette Life Sciences, INC. | $37.61 | 2022 | |
| Urovant Sciences INC | $32.93 | 2021 | |
| Smith+Nephew, INC. | $29.74 | 2021 | |
| Urogen Pharma, INC. | $25.41 | 2021 | |
| Zyla Life Sciences, INC. | $24.91 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.65 | 2019 | |
| Laborie Medical Technologies Corp. | $23.95 | 2020 | |
| Ferring Pharmaceuticals INC. | $22.72 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.58 | 2022 | |
| Medtronic USA, INC. | $20.51 | 2020 | |
| Convatec INC. | $20.42 | 2019 | |
| Olympus America INC. | $17.10 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.21 | 2021 | |
| Myriad Genetic Laboratories, INC. | $14.03 | 2021 | |
| Sun Pharmaceutical Industries INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.